[1]
Hanumant Gambhire, Monica Gulati*, Sachin Kumar Singh, Ankit Kumar, Atul Nasa & Neelu Goel, “Impact of USFDA Warning Letters on Economic Growth of Indian Pharmaceutical Industry”, AS, vol. 24, no. 4, pp. 46–55, Aug. 2023.